Co-Expression of Urokinase With Haptoglobin in Human Carcinomas

Journal of Surgical Research

Volumn 152, Issue 2, 2009, Pages 189-197

  Harvey, Shashikumar ^a   Kohga, Shin ^a   Sait, Sheila N J ^a   Markus, Gabor ^a   Hurd, Thelma C ^a,b   Martinick, Maisie ^a,b   Geradts, Joseph ^a   Saxena, Rakhee ^a   Gibbs, John F ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

FISH; haptoglobin; immunohistochemistry; tumor markers; urokinase

Indexed keywords

HAPTOGLOBIN; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; UROKINASE;

ANTIGEN EXPRESSION; ARTICLE; BETA CHAIN; BREAST ADENOCARCINOMA; CANCER CELL; CAPILLARY ENDOTHELIUM; CELL MEMBRANE; CLINICAL ARTICLE; COLON ADENOCARCINOMA; CYTOPLASM; ENDOTHELIUM CELL; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; STROMA CELL;

BREAST NEOPLASMS; COLONIC NEOPLASMS; FEMALE; HAPTOGLOBINS; HUMANS; IN SITU HYBRIDIZATION; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASM STAGING; RNA, MESSENGER; RNA, NEOPLASM; SIGMOID NEOPLASMS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 61849097798     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.06.016     Document Type: Article

References (22)

1. El Ghmati S.M., Van Hoeyveld E.M., Van Strijp J.G., et al. Identification of haptoglobin as an alternative ligand for CD11b/CD18. J Immunol 156 (1996) 2542
2. Gutteridge J.M. The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation. Biochim Biophys Acta 917 (1987) 219
3. Snellman O., and Sylven B. Haptoglobin acting as a natural inhibitor of cathepsin B activity. Nature 216 (1967) 1033
4. Kim I.K., Lee J.H., Kim H.S., et al. A novel function of haptoglobin: haptoglobin-haemoglobin complex induces apoptosis of hepatocarcinomatous Hep 3B cells. Scand J Clin Lab Invest 55 (1995) 529
5. Cid M.C., Grant D.S., Hoffman G.S., et al. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 91 (1993) 977
6. Harvey W., Srour E.F., Turner R., et al. Characterization of a new cell line (ESKOL) resembling hairy-cell leukemia: A model for oncogene regulation and late B-cell differentiation. Leuk Res 15 (1991) 733
7. Harvey S.R., Nayak S.K., Markus G., et al. Cancer cells release a covalent complex containing disulfide-linked domains from urinary plasminogen activator, neural cell adhesion molecule, and haptoglobin alpha and beta chains. Arch Biochem Biophys 345 (1997) 289
8. Harvey S.R., Sait S.N., Xu Y., et al. Demonstration of urokinase expression in cancer cells of colon adenocarcinomas by immunohistochemistry and in situ hybridization. Am J Pathol 155 (1999) 1115
9. Hurd T.C., Sait S., Kohga S., et al. Plasminogen activator system localization in 60 cases of ductal carcinoma in situ. Ann Surg Oncol 14 (2007) 3117
10. Grondahl-Hansen J., Ralfkiaer E., Kirkeby L., et al. Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. Am J Pathol 138 (1991) 111
11. Pyke C., Kristensen P., Ralfkiaer E., et al. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Pathol 138 (1991) 1059
12. Hewitt R., and Dano K. Stromal cell expression of components of matrix-degrading protease systems in human cancer. Enzyme Protein 49 (1996) 163
13. Kohga S., Harvey S.R., Weaver R.M., et al. Localization of plasminogen activators in human colon cancer by immunoperoxidase staining. Cancer Res 45 (1985) 1787
14. Kohga S., Harvey S., Suzumiya J., Sumiyoshi A., and Markus G. Comparison of the immunohistochemical localization of urokinase in normal and cancer human colon tissue. Fibrinolysis 3 (1989) 17-22
15. Oh S.K., Very D.L., Walker J., et al. An analogy between fetal haptoglobin and a potent immunosuppressant in cancer. Cancer Res 47 (1987) 5120
16. Elg S.A., Carson L.F., Fowler J.M., et al. Ascites levels of haptoglobin in patients with ovarian cancer. Cancer 71 (1993) 3938
17. Kuhajda F.P., Piantadosi S., and Pasternack G.R. Haptoglobin-related protein (Hpr) epitopes in breast cancer as a predictor of recurrence of the disease. New Engl J Med 321 (1989) 636
18. Langlois M.R., and Delanghe J.R. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42 (1996) 1589
19. Kuhajda F.P., Katumuluwa A.I., and Pasternack G.R. Expression of haptoglobin-related protein and its potential role as a tumor antigen. Proc Natl Acad Sci USA 86 (1989) 1188
20. Schmitt M., Wilhelm O., Reuning U., et al. The urokinase plasminogen activator system as a novel target for tumour therapy. Fibrinolysis Proteolysis 14 (2000) 14
21. Nielsen B., Sehested M., Timshel S., et al. Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer. Lab Invest 74 (1996) 168
22. Harvey S.R., Lawrence D.D., Madeja J.M., et al. Secretion of plasminogen activators by human colorectal and gastric tumor explants. Clin Exp Metastasis 6 (1988) 431